论文部分内容阅读
上海市科委在软课题项目“上海制药业发展策略研究”报告的基础上,于6月19日举办了上海制药业发展研讨会。有关研究所、制药企业及管理部门等50余名代表就如何促进上海制药业发展,加快科研技术开发成果的转化及产业进程,加强科研院所与企业的交流等问题发表了真知灼见。 会议由上海市科委体改处钱维昌处长主持,科委副主任张鳌出席会议,上海市现代生物与医药产业办公室王建平处长就上海医药发展作要点发言。上海医药工业研究院院长黄成龙作了题为“发挥科技优势,拓展合作群体,协力建设上海医药新高地”的报告,较全面地介绍了上海医药工业研究院20年来取得的丰硕成果。该院前后共获得新药证
The Shanghai Science and Technology Commission held a seminar on the development of the Shanghai pharmaceutical industry on June 19 on the basis of the report on the “Study on the Development Strategies of the Shanghai Pharmaceutical Industry” of the Soft Project. More than 50 representatives from research institutes, pharmaceutical companies and management departments expressed their insights on how to promote the development of Shanghai’s pharmaceutical industry, accelerate the transformation of scientific research and technological development achievements and industrial progress, and strengthen exchanges between scientific research institutes and enterprises. The meeting was chaired by the Director of the Department of Economic Restructuring of the Shanghai Municipal Science and Technology Commission, Qian Weichang, and Zhang Jian, Deputy Director of the Science and Technology Commission attended the meeting. Wang Jianping, Director of the Shanghai Municipal Office of Modern Biology and Pharmaceutical Industry gave a keynote speech on Shanghai Pharmaceutical Development. Huang Chenglong, president of the Shanghai Pharmaceutical Industry Research Institute, made a report entitled “Utilize scientific and technological advantages, expand cooperation groups, and work together to build a new height of Shanghai medicine”, and introduced the fruitful achievements of the Shanghai Institute of Pharmaceutical Industry in 20 years. A total of new drug certificates were obtained before and after the hospital